Virtual Medical International, Inc. (QEBR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 69.44 Thousand | - | - | - |
| Cost of Revenue | - | - | 42.08 Thousand | - | - | - |
| Gross Profit | - | - | 27.36 Thousand | - | - | - |
| Operating Expenses | 13.12 Million | 4.55 Million | 126.61 Thousand | 26.18 Thousand | 8043.00 | 4893.00 |
| Selling, General and Administrative Expenses | 13.12 Million | 4.55 Million | 101.09 Thousand | 26.18 Thousand | 8043.00 | 4893.00 |
| Research and Development Expenses | - | - | 25.52 Thousand | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 13.12 Million | 4.55 Million | 168.7 Thousand | 26.18 Thousand | 8043.00 | 4893.00 |
| Operating Income | -13.12 Million | -4.55 Million | -99.26 Thousand | -26.19 Thousand | -8040.00 | -4890.00 |
| Interest Expense | - | - | - | 250.00 | - | - |
| Income Tax Expense | -236.55 Thousand | -61.93 Thousand | -5.01 Million | - | - | - |
| Earnings before Tax | -13.72 Million | -15.71 Million | -21.58 Million | -124.67 Thousand | -14.73 Thousand | -4893.00 |
| Net Income | -13.72 Million | -15.65 Million | -16.56 Million | -124.67 Thousand | -14.73 Thousand | -4893.00 |
| Earnings Per Share Basic | -0.02 | -0.03 | -0.04 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.02 | -0.03 | -0.04 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 665.85 Million | 451.17 Million | 428.9 Million | 414.74 Million | 114.81 Million | 55.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 665.85 Million | 451.17 Million | 428.9 Million | 414.74 Million | 114.81 Million | 55.36 Million |
| Gross Margin | - | - | 0.39 | - | - | - |
| EBIT Margin | - | - | -1.43 | - | - | - |
| Profit Margin | - | - | -238.57 | - | - | - |
| EBITDA | -13.72 Million | -15.71 Million | -21.58 Million | -124.42 Thousand | -8043.00 | -4893.00 |
| Earnings Before Tax Margin | - | - | -1.43 | - | - | - |
| Breakdown | 2022 Q1 | 2021 Q4 | 2021 FY | 2021 Q3 | 2021 Q2 | 2021 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 184.52 Thousand | 149.64 Thousand | 13.12 Million | 10.27 Million | 2.2 Million | 491.85 Thousand |
| Selling, General and Administrative Expenses | 184.52 Thousand | 149.64 Thousand | - | 10.27 Million | 2.2 Million | 491.85 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 184.52 Thousand | 149.64 Thousand | 13.12 Million | 10.27 Million | 2.2 Million | 491.85 Thousand |
| Operating Income | -184.53 Thousand | -149.64 Thousand | -13.12 Million | -10.27 Million | -2.2 Million | -491.86 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | -236.55 Thousand | - | - | - |
| Earnings before Tax | -184.52 Thousand | -321.64 Thousand | -13.72 Million | -10.27 Million | -2.63 Million | -491.85 Thousand |
| Net Income | -184.52 Thousand | -321.64 Thousand | -13.72 Million | -10.27 Million | -2.63 Million | -491.85 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.01 | -0.01 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.01 | -0.01 | -0.00 |
| Weighted Average Shares Outstanding | 941.08 Million | 941.08 Million | 665.85 Million | 746.55 Million | 494.19 Million | 475.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 941.08 Million | 941.08 Million | 665.85 Million | 746.55 Million | 494.19 Million | 475.58 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -184.53 Thousand | -149.64 Thousand | - | -10.27 Million | -2.2 Million | -491.86 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
LVCLF
GLAXF
STSB
IGLDF
TPIC
002321